“∋ yeotop4.com ∈ 신목동오피ょ신목동휴게텔❃신목동풀싸롱❟신목동출장ん신목동오피だ신목동건마ⅱ신목동스파”的搜索结果，显示 161-170 项，共有 7030 项

1. 神经科- 临床试验- 妙佑医疗国际

   ... N-acetylaspartate (NAA) and aberrations of the phospholipid signature of neurological tissue; and to identify the presence of IDH mutations by monitoring the 2 ...

2. 神经科- 临床试验- 妙佑医疗国际

   ... (2) early onset non-Alzheimer's Disease (EO-nonAD) participants,and (3) cognitively normal (CN) control participants. A Study of Nivolumab and Multi-fraction ...

3. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

   2. Olmsted County residents at the time of study entry. Exclusion criteria: 1. Pediatric population (age<18). 2. Unwilling to participate or unable to consent.

4. 神经科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this post-approval study is to further evaluate the long-term safety and effectiveness of Medtronic DBS therapy for epilepsy on ...

5. 神经科- 临床试验- 妙佑医疗国际

   ... N-acetylaspartate (NAA) and aberrations of the phospholipid signature of neurological tissue; and to identify the presence of IDH mutations by monitoring the 2 ...

6. 神经科- 临床试验- 妙佑医疗国际

   The objectives of this study are to determine the Maximum Tolerated Dose (MTD) and the Recommended Phase 2 Dose (RP2D) of NMS-03305293 in combination with ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Jacksonville, Fla. The purpose of this study is to compare the effects on low-risk breast cancer receiving usual care that includes regional radiation therapy, ...

8. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this registry is to collect clinical, diagnostic, and therapeutic data specific for primary spinal column tumor patients, and evaluate it to ...

9. 神经科- 临床试验- 妙佑医疗国际

   ... N-acetylaspartate (NAA) and aberrations of the phospholipid signature of neurological tissue; and to identify the presence of IDH mutations by monitoring the 2 ...

10. 神经科- 临床试验- 妙佑医疗国际

    The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...